Co-Delivery of Paclitaxel Prodrug, Gemcitabine and Porphine by Micelles for Pancreatic Cancer Treatment via Chemo-Photodynamic Combination Therapy
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Co-Delivery of Paclitaxel Prodrug, Gemcitabine and Porphine by Micelles for Pancreatic Cancer Treatment via Chemo-Photodynamic Combination Therapy
Authors
Keywords
-
Journal
Pharmaceutics
Volume 14, Issue 11, Pages 2280
Publisher
MDPI AG
Online
2022-10-26
DOI
10.3390/pharmaceutics14112280
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rational design of mixed nanomicelle eye drops with structural integrity investigation
- (2022) Liping Sun et al. Acta Biomaterialia
- An Energy‐Storing DNA‐Based Nanocomplex for Laser‐Free Photodynamic Therapy
- (2022) Huaixin Zhao et al. ADVANCED MATERIALS
- Chemotherapy in pancreatic ductal adenocarcinoma: When cytoreduction is the aim. A systematic review and meta-analysis
- (2022) Monica I. Meneses-Medina et al. CANCER TREATMENT REVIEWS
- Co‐Delivery of Paclitaxel and shMCL‐1 by Folic Acid‐Modified Nonviral Vector to Overcome Cancer Chemotherapy Resistance
- (2021) Wen Nie et al. Small Methods
- Cancer‐Cell‐Activated In‐Situ Synthesis of Mitochondria‐Targeting AIE Photosensitizer for Precise Photodynamic Therapy
- (2021) Yuanbo Wang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Everolimus regulates the activity of gemcitabine-resistant pancreatic cancer cells by targeting the Warburg effect via PI3K/AKT/mTOR signaling
- (2021) Jing Cui et al. MOLECULAR MEDICINE
- Advances in Nanomaterial-Mediated Photothermal Cancer Therapies: Toward Clinical Applications
- (2021) Hwa Seung Han et al. Biomedicines
- Nanoparticulation of Prodrug into Medicines for Cancer Therapy
- (2021) Yuezhou Zhang et al. Advanced Science
- Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer
- (2021) Xidong Tian et al. ACS Applied Materials & Interfaces
- LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway
- (2021) Fengyu Xu et al. CANCER RESEARCH
- MoO3-x nanosheets-based platform for single NIR laser induced efficient PDT/PTT of cancer
- (2021) Fan Wu et al. JOURNAL OF CONTROLLED RELEASE
- Recent advances in selective photothermal therapy of tumor
- (2021) Liping Zhao et al. JOURNAL OF NANOBIOTECHNOLOGY
- Construction of disulfide containing redox-responsive polymeric nanomedicine
- (2021) Shiwei Fu et al. METHODS
- Germline genetic variability in pancreatic cancer risk and prognosis
- (2020) Manuel Gentiluomo et al. SEMINARS IN CANCER BIOLOGY
- Polymeric Nanoparticles with ROS‐Responsive Prodrug and Platinum Nanozyme for Enhanced Chemophotodynamic Therapy of Colon Cancer
- (2020) Ying Hao et al. Advanced Science
- Gemcitabine-retinoid prodrug loaded nanoparticles display in vitro antitumor efficacy towards drug-resilient human PANC-1 pancreatic cancer cells
- (2020) Hamilton Kakwere et al. Materials Science & Engineering C-Materials for Biological Applications
- Real world evidence on gemcitabine and nab-paclitaxel combination chemotherapy in advanced pancreatic cancer
- (2019) Hakon Blomstrand et al. BMC CANCER
- The expanding role of prodrugs in contemporary drug design and development
- (2018) Jarkko Rautio et al. NATURE REVIEWS DRUG DISCOVERY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Photothermal therapy and photoacoustic imaging via nanotheranostics in fighting cancer
- (2018) Yijing Liu et al. CHEMICAL SOCIETY REVIEWS
- The Endosomal Escape of Nanoparticles: Toward More Efficient Cellular Delivery
- (2018) Samuel A. Smith et al. BIOCONJUGATE CHEMISTRY
- Lipoic acid metabolism and mitochondrial redox regulation
- (2017) Ashley Solmonson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Glutathione-responsive paclitaxel dimer nanovesicles with high drug content
- (2017) Qing Pei et al. Biomaterials Science
- Self-Assembly of Porphyrin-Paclitaxel Conjugates Into Nanomedicines: Enhanced Cytotoxicity due to Endosomal Escape
- (2016) Xiaohua Zheng et al. Chemistry-An Asian Journal
- Use of a Lipid-Coated Mesoporous Silica Nanoparticle Platform for Synergistic Gemcitabine and Paclitaxel Delivery to Human Pancreatic Cancer in Mice
- (2015) Huan Meng et al. ACS Nano
- DSPE-PEG: A Distinctive Component in Drug Delivery System
- (2015) Jing Che et al. CURRENT PHARMACEUTICAL DESIGN
- Gemcitabine resistance in pancreatic ductal adenocarcinoma
- (2015) Yoav Binenbaum et al. DRUG RESISTANCE UPDATES
- Nab-paclitaxel: A flattering facelift
- (2014) A. Viúdez et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Prodrug-based intracellular delivery of anticancer agents
- (2011) L. Bildstein et al. ADVANCED DRUG DELIVERY REVIEWS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started